Medical Health & Life Science Research News

Research details developments in Alzheimer's disease drugs industry forecast to 2020

Alzheimer's disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages.

- Agency -.

"Global Alzheimer's Disease Drugs Market & Pipeline Drugs Market Analysis to 2020" is a 150 page report with 74 Figures and 10 Tables. This report analyses the Alzheimer's Disease Drugs Market, Alzheimer's Disease Pipeline Drugs Market and Clinical Trials Analysis, Alzheimer's Disease - Country Wise Drugs Market, Country Wise Alzheimer's Disease Prevalence, Major Deals in Alzheimer's Disease Drugs Market Landscape, Funding in Alzheimer's Disease Drugs Research, Driving Factors and Challenges for Alzheimer's Disease Drugs Market.

Complete report available at www.marketreportsonline.com/481212.html.

- Agency -.

With the ageing global population, the number of patients suffering from Alzheimer's disease is predicted to grow during the forecasting period.

Alzheimer's treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired.

The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.

Global Alzheimer's Disease Drugs Market and Pipeline Drugs Analysis: In 2014, the global market for Alzheimer's disease drugs was dominated by Namenda and Exelon. Aricept and Memary stands at the third and fourth spot respectively in terms of Alzheimer's disease drugs sales in 2014.

Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer's disease market. With the patent expiration of popular drugs the sales of the Alzheimer's drugs has also declined.

However, there are several pipeline drugs like Solanezumab, Gantenerumab, Crenezumab and Lu AE58054 among others which are likely to hit the market during the period 2017 - 2020.

Global Alzheimer's Disease Country Wise Analysis: In the Alzheimer's disease drugs market, the United States is the largest market. Japan is the second leading market for Alzheimer's disease drugs market accounting for XXX% market share in 2014.

China stands at the third spot in the global Alzheimer's disease drugs market being followed by India with XXX% share in the same year. The EU5 countries together accounted for over XXX% share of the global Alzheimer's disease drugs market in 2014.

Access a copy of this report at www.marketreportsonline.com/contacts/purchase.php?name=481212.

The Alzheimer's Disease Drugs Market has been analyzed from 7 View Points:

Alzheimer's Disease - Drugs Sales and Forecast

Alzheimer's Disease - Pipeline Drugs Sales Forecast

Alzheimer's Disease Drugs - Country Wise Market and Forecast

Alzheimer's Disease - Country Wise Prevalence and Forecast

Alzheimer's Disease - Pipeline Drugs Clinical Trials Analysis

Alzheimer's Disease - Major Deals in Alzheimer's Drugs Market

Alzheimer's Disease - Funding in Alzheimer's Disease Research

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.